Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574119 · ClinicalTrials.gov registry record · Phase 4
Effect of Aldosterone on Energy Starvation in Heart Failure
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00574119 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 16 participants.
The verdict
NCT00574119, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magnetic resonance imaging to study metabolism, anatomy, function, blood flow and efficiency, before and after 6 months' treatment with the drug spironolactone which blocks the deleterious effects of the hormone aldosterone on the myocardium (heart muscle).
Interventions
- DRUG spironolactone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-12 |
| Est. Completion | 2012-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574119
The ClinicalTrials.gov registry entry for NCT00574119 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which spironolactone is the first listed.
NCT00574119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574119 about?
NCT00574119 is a clinical study titled "Effect of Aldosterone on Energy Starvation in Heart Failure". We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magneti...
What is the current status of trial NCT00574119?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2007-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00574119?
The interventions under investigation include: spironolactone (DRUG).
Who is sponsoring clinical trial NCT00574119?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.